Business Description
Shanghai Hile Bio-Technology Co Ltd
ISIN : CNE1000022T4
Share Class Description:
SHSE:603718: Class ACompare
Compare
Traded in other countries / regions
603718.China IPO Date
2015-05-15Description
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.4 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -7.49 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.03 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.7 | |||||
| 3-Year EBITDA Growth Rate | 39.7 | |||||
| 3-Year Book Growth Rate | 4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.1 | |||||
| 9-Day RSI | 50.18 | |||||
| 14-Day RSI | 53.67 | |||||
| 6-1 Month Momentum % | 7.2 | |||||
| 12-1 Month Momentum % | -31.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.15 | |||||
| Quick Ratio | 2.92 | |||||
| Cash Ratio | 0.6 | |||||
| Days Inventory | 316.93 | |||||
| Days Sales Outstanding | 159.21 | |||||
| Days Payable | 75.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.34 | |||||
| Dividend Payout Ratio | 4.83 | |||||
| 3-Year Dividend Growth Rate | 111.8 | |||||
| Forward Dividend Yield % | 0.34 | |||||
| 5-Year Yield-on-Cost % | 0.36 | |||||
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | -0.15 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.04 | |||||
| Operating Margin % | -19.89 | |||||
| Net Margin % | 3.78 | |||||
| FCF Margin % | 28.97 | |||||
| ROE % | 0.68 | |||||
| ROA % | 0.51 | |||||
| ROIC % | 0.09 | |||||
| ROC (Joel Greenblatt) % | -3.25 | |||||
| ROCE % | -0.7 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 907.78 | |||||
| PE Ratio without NRI | 1361.67 | |||||
| Shiller PE Ratio | 68.08 | |||||
| PEG Ratio | 71.29 | |||||
| PS Ratio | 20.15 | |||||
| PB Ratio | 4.21 | |||||
| Price-to-Tangible-Book | 5.27 | |||||
| Price-to-Free-Cash-Flow | 92.87 | |||||
| Price-to-Operating-Cash-Flow | 78.57 | |||||
| EV-to-EBIT | -615.03 | |||||
| EV-to-EBITDA | -615.03 | |||||
| EV-to-Revenue | 24.2 | |||||
| EV-to-FCF | 81.17 | |||||
| Price-to-Projected-FCF | 3.27 | |||||
| Price-to-Graham-Number | 17.76 | |||||
| Price-to-Net-Current-Asset-Value | 6.59 | |||||
| Earnings Yield (Greenblatt) % | -0.16 | |||||
| FCF Yield % | 1.18 | |||||
| Forward Rate of Return (Yacktman) % | -24.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Hile Bio-Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 220.548 | ||
| EPS (TTM) (Â¥) | 0.009 | ||
| Beta | 0.99 | ||
| Volatility % | 39.31 | ||
| 14-Day RSI | 53.67 | ||
| 14-Day ATR (Â¥) | 0.37818 | ||
| 20-Day SMA (Â¥) | 8.2275 | ||
| 12-1 Month Momentum % | -31.09 | ||
| 52-Week Range (Â¥) | 5.74 - 11.38 | ||
| Shares Outstanding (Mil) | 657.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Hile Bio-Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Hile Bio-Technology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Hile Bio-Technology Co Ltd Frequently Asked Questions
What is Shanghai Hile Bio-Technology Co Ltd(SHSE:603718)'s stock price today?
The current price of SHSE:603718 is ¥8.17. The 52 week high of SHSE:603718 is ¥11.38 and 52 week low is ¥5.74.
When is next earnings date of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718)?
The next earnings date of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) is .
Does Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) is 0.34% (As of Today), Highest Dividend Payout Ratio of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) was 5.5. The lowest was 0.1. And the median was 0.5. The  Forward Dividend Yield % of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) is 0.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers